Oscar Health (OSCR) Projected to Release Earnings on Thursday

Oscar Health (NYSE:OSCR) is anticipated to post its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Oscar Health to post earnings of ($0.1438) per share and revenue of $4.69 billion for the quarter. Parties can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. During the same period in the previous year, the firm posted ($0.89) earnings per share. The firm’s revenue for the quarter was up 70.4% on a year-over-year basis. On average, analysts expect Oscar Health to post $1.83 EPS for the current fiscal year and $2.22 EPS for the next fiscal year.

Oscar Health Trading Down 3.1%

OSCR opened at $30.39 on Thursday. Oscar Health has a fifty-two week low of $10.69 and a fifty-two week high of $35.01. The firm has a market capitalization of $9.38 billion, a PE ratio of 21.71, a P/E/G ratio of 0.34 and a beta of 2.47. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The company’s 50-day moving average is $31.74 and its 200 day moving average is $23.45.

Analysts Set New Price Targets

Several analysts have recently commented on OSCR shares. Raymond James Financial increased their price objective on Oscar Health from $34.00 to $42.00 and gave the stock an “outperform” rating in a research note on Friday, September 18th. Wells Fargo & Company lifted their target price on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. The Goldman Sachs Group reiterated a “neutral” rating and set a $34.00 price target on shares of Oscar Health in a report on Thursday, September 17th. Stephens reissued an “equal weight” rating and issued a $34.00 price target on shares of Oscar Health in a research report on Thursday, September 17th. Finally, Barclays raised their price objective on Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a research note on Thursday, September 17th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $34.90.

Insiders Place Their Bets

In other Oscar Health news, CAO Victoria Baltrus sold 958 shares of Oscar Health stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $30,129.10. Following the transaction, the chief accounting officer owned 213,631 shares of the company’s stock, valued at $6,718,694.95. This trade represents a 0.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Blackley sold 28,869 shares of Oscar Health stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $907,930.05. Following the transaction, the chief financial officer directly owned 1,046,108 shares in the company, valued at approximately $32,900,096.60. This represents a 2.69% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 874,451 shares of company stock worth $26,761,671 in the last ninety days. 22.64% of the stock is owned by corporate insiders.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.